Health care stocks can give you some shelter from the storm of a monstrous bear market.
Health care stocks are typically a viable option when the rest of the market is volatile.
Health care stocks are starting to perform a little bit better, which may signal that the market is viewing a Republican victory favorably.
FORBES: Q4 Expected Growth Rate Is Low, All Eyes On Quant Easing
The recent positive performance of health care stocks and staples which typically have similar fundamentals at this point of the business cycle may ignite equity markets.
FORBES: Q4 Expected Growth Rate Is Low, All Eyes On Quant Easing
He prefers investing in property rather than health care stocks because buildings, such as hospitals, will be needed regardless of the final universal health care bill.
As a result, health care stocks remained weak even as the broad market, led by resurgent cyclical stocks such as Caterpillar ( CAT), mounted an exuberant recovery.
FORBES: St. Jude's Emerges From Shadow Of Health Care Reform
Moroney added three non-pharmaceutical health care stocks to Dow Theory's Focus List, which, according to the Hulbert Financial Digest, has returned an average of 11.6% per year over the five years ended Dec. 31, 2001.
Broad baskets of health care stocks are hitting new multiyear and all-time highs, led by breakouts in biotechnology and a big move higher by pharmaceuticals, proving that you can play offense even in defensive positions.
Health care stocks experienced the largest losses.
FORBES: Lackluster Job Growth Raises Likelihood Of Fed Action
For all the talk of health care stocks sickening in the wake of Obama Care, health plan providers have held steady, evidenced by the iShares Dow Jones U.S. Healthcare Provider ETF (IHF) trading at the same level as it was in mid-March when the health care reform bill was passed.
Novartis ( NVS), Roche ( RHHBY), some of the best health-care stocks in the world.
Leading the gains on Tuesday were health-care stocks, already the best-performing sector of the year.
These two health-care stocks fit this criteria and are quite close to their buy levels.
Leading the gains were health-care stocks, already the best-performing sector of the year.
In the early part of the year, gains have been led by defensive sectors, such as health-care stocks, consumer-staples companies and utilities.
Despite the gains in many health-care stocks, there are still some that are just turning higher from support and are likely to hold up better if the market does correct.
In addition to the gains among health-care stocks, consumer-staples and telecommunications stocks outpaced the broader benchmark, a reminder to market watchers that the year's gains have been driven mostly by less economically sensitive stocks.
Weighing on the downside were health-care stocks.
WSJ: Technology Shares Shine Again, Pushing S&P 500 to Another Record Close
When the same question was asked last November, members favored energy and technology stocks, followed by health care and utility stocks.
Investors looking for individual stocks should consider health care, energy and tech stocks with above-average dividend yields, says Mark Luschini, chief investment strategist at Janney Montgomery Scott.
Leading the gains were health care and financial stocks, while telecommunications and technology shares weighed on the downside.
Many members also said they favor health care and pharmaceutical stocks.
They have bought and sold health-care and financial stocks based on their expected future earnings.
Health-care companies and financial stocks still look attractive, according to Mr. Ablin and others.
Among these stocks are Health Care Reit Inc. (NYSE: HCN), which gained more than 2% in four days after being targeted and tweeted from need2knowstocks.
With their stocks down, health care REITs are cheap in comparison with the estimated liquidating value of their assets.
Amgen, Inc. (AMGN) is one of my favorite stocks held by health care ETFs and mutual funds and earns my very attractive rating.
One of the top health-care areas have been drug stocks, and the Pharmaceutical Index (DRG) is up close to 18% from the June lows.
Sarapta Therapeutics (SRPT) is one of my least favorite stocks held by health care ETFs and mutual funds and earns my very dangerous rating.
应用推荐